Nutriband Overview

  • Status
  • Public

  • Employees
  • 3

Employees

  • Stock Symbol
  • NTRB

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $2.43
  • (As of Monday Closing)

Nutriband General Information

Description

Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Drug Delivery
Stock Exchange
NAS
Corporate Office
  • 121 South Orange Avenue
  • Suite 1500
  • Orlando, FL 32801
  • United States
+1 (407) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nutriband Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.43 $2.40 $1.53 - $5.15 $20.6M 8.46M 8.1K -$0.67

Nutriband Financials Summary

In Thousands,
USD
TTM 31-Oct-2023 FY 2023 31-Jan-2023 FY 2022 31-Jan-2022 FY 2021 31-Jan-2021
EV 17,557 25,974 28,712 111,979
Revenue 2,088 2,080 1,422 944
EBITDA (4,918) (4,106) (5,739) (2,482)
Net Income (5,284) (4,483) (6,176) (2,933)
Total Assets 8,523 9,456 12,740 9,927
Total Debt 2,254 186 135 1,788
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nutriband Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nutriband‘s full profile, request access.

Request a free trial

Nutriband Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA tech
Drug Delivery
Orlando, FL
3 As of 2023
00.000
00000000

000000

nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qu
0000 00000000
Miami, FL
00 As of 0000
000000000 -

000000

abore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000 00000000
Fremont, CA
00 As of 0000
00000
00 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nutriband Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Prosolus Corporate Backed or Acquired Miami, FL 00 000000000 -
Zosano Pharma Formerly VC-backed Fremont, CA 00 00000 000000&0
Catalent Formerly PE-Backed Somerset, NJ 00000 000.00 000000000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

Nutriband Patents

Nutriband Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11246840-B2 Abuse and misuse deterrent transdermal systems Active 22-Jan-2014 0000000000 00
US-20200113845-A1 Abuse and misuse deterrent transdermal systems Active 22-Jan-2014 0000000000 0
US-20220125739-A1 Abuse and misuse deterrent transdermal systems Active 22-Jan-2014 0000000000
US-11759431-B2 Abuse and misuse deterrent transdermal systems Active 22-Jan-2014 0000000000 00
US-20240000720-A1 Abuse and misuse deterrent transdermal systems Pending 22-Jan-2014 A61K9/7084
To view Nutriband’s complete patent history, request access »

Nutriband Executive Team (9)

Name Title Board Seat Contact Info
Gareth Sheridan Co-Founder, Chief Executive Officer & Board Member
Alan Smith Ph.D Head of Clinical, Regulatory, Quality, & Operations
Gerald Goodman Chief Financial Officer & Chief Accounting Officer
Paddy Ryan Chief Technical Officer
Jeff Patrick Ph.D Chief Scientific Officer
You’re viewing 5 of 9 executive team members. Get the full list »

Nutriband Board Members (9)

Name Representing Role Since
Gareth Sheridan Nutriband Co-Founder, Chief Executive Officer & Board Member 000 0000
Irina Gram-Contulescu Nutriband Board Member 000 0000
Radu Bujoreanu Nutriband Board Member 000 0000
Serguei Melnik Nutriband Chairman & Founder 000 0000
Stefan Mancas Nutriband Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Nutriband Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nutriband Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Active Intelligence (USA) 31-Aug-2020 0000000000 Medical Supplies
Pocono Coated Products 31-Aug-2020 0000000000 00.000 Pharmaceuticals 000000 00
Carmel Biosciences 19-Nov-2018 0000000000 00.00 Pharmaceuticals 000000 00
4P Therapeutics 01-Aug-2018 0000000000 00.000 Drug Delivery 000000 00
Advanced Health Brands 22-May-2017 Merger/Acquisition 00.00 Biotechnology 000000 00
To view Nutriband’s complete acquisitions history, request access »

Nutriband Subsidiaries (2)

Company Name Industry Location Founded
Active Intelligence (USA) Medical Supplies Cherryville, NC 2017
Pocono Coated Products Pharmaceuticals Cherryville, NC 0000
To view Nutriband’s complete subsidiaries history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »